Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to eyeball08,Wondergirly,bofh,johnstevens77,Bhoddhisatva, for Donating to support the site

AstraZeneca - Update on Farxiga COVID-19 DARE-19 Phase III trial posted on Company News Board.

For discussion of the practicalities of setting up and operating income-portfolios which follow the HYP Group Guidelines. READ Guidelines before posting
Forum rules
Tight HYP discussions only please - OT please discuss in strategies
idpickering
The full Lemon
Posts: 11349
Joined: November 4th, 2016, 5:04 pm
Has thanked: 2475 times
Been thanked: 5794 times

AstraZeneca - Update on Farxiga COVID-19 DARE-19 Phase III trial posted on Company News Board.

#403510

Postby idpickering » April 12th, 2021, 7:15 am

Here; viewtopic.php?p=403508#p403508

AZN are a mainstay in my HYP, and I guess, that of many HYPers hereabouts. TBH, I wouldn't buy them as a newbie holding now, as the yield isn't that attractive imho. I'm happy to continue holding AZN though, although I've been buying more GSK recently.

On first glance of this AZN announcement, it all appears disappointing news imho.

Ian.

Return to “HYP Practical (See Group Guidelines)”

Who is online

Users browsing this forum: idpickering and 34 guests